Gabizon Ronen, Mor Michal, Rosenberg Masha M, Britan Lena, Hayouka Zvi, Kotler Moshe, Shalev Deborah E, Friedler Assaf
Institute of Chemistry, The Hebrew University of Jerusalem, Safra Campus, Givat Ram, Jerusalem 91904, Israel.
Biopolymers. 2008;90(2):105-16. doi: 10.1002/bip.20919.
Peptides are valuable tools for studying protein-protein interactions, especially in cases of isolated protein domains and natively unfolded proteins. Here, we used peptides to quantitatively characterize the interaction between the natively unfolded HIV-1 Tat protein and the tetramerization domain of the cellular tumor suppressor protein p53. We used peptide mapping, fluorescence anisotropy, and NMR spectroscopy to perform a detailed structural and biophysical characterization of the interaction between the two proteins and elucidate its molecular mechanism, which have so far been studied using cell-based methods. We show that the p53 tetramerization domain, p53(326-355), binds directly to residues 1-35 and 47-57 in Tat. We have characterized the interaction between p53(326-355) and Tat(47-57) in detail. The p53 residues that are mainly involved in binding to Tat(47-57) are E343 and E349, which bind to the positively charged arginine-rich motif of Tat by a partly electrostatic mechanism. All oligomerization states of p53(326-355) bind Tat(47-57) without inhibiting p53 tetramerization, since the residues in p53(326-355) that bind Tat(47-57) face away from the tetramerization interface. We conclude that p53 is able to bind Tat as a transcriptionally active tetramer.
肽是研究蛋白质 - 蛋白质相互作用的重要工具,特别是在分离的蛋白质结构域和天然未折叠蛋白质的情况下。在这里,我们使用肽来定量表征天然未折叠的HIV-1 Tat蛋白与细胞肿瘤抑制蛋白p53的四聚化结构域之间的相互作用。我们使用肽图谱、荧光各向异性和核磁共振光谱对这两种蛋白质之间的相互作用进行了详细的结构和生物物理表征,并阐明了其分子机制,迄今为止这些研究一直使用基于细胞的方法。我们表明,p53四聚化结构域p53(326 - 355)直接与Tat中的1 - 35位和47 - 57位残基结合。我们已经详细表征了p53(326 - 355)与Tat(47 - 57)之间的相互作用。主要参与与Tat(47 - 57)结合的p53残基是E343和E349,它们通过部分静电机制与Tat的富含精氨酸的带正电荷基序结合。p53(326 - 355)的所有寡聚化状态都能结合Tat(47 - 57)而不抑制p53四聚化,因为p53(326 - 355)中与Tat(47 - 57)结合的残基背对四聚化界面。我们得出结论,p53能够作为转录活性四聚体结合Tat。